|
Q4 FY2016
As of Jun 30, 2016
|
Q3 FY2016
As of Mar 31, 2016
|
Q2 FY2016
As of Dec 31, 2015
|
Q1 FY2016
As of Sep 30, 2015
|
Q4 FY2015
As of Jun 30, 2015
|
Q3 FY2015
As of Mar 31, 2015
|
Q2 FY2015
As of Dec 31, 2014
|
Q1 FY2015
As of Sep 30, 2014
|
Q4 FY2014
As of Jun 30, 2014
|
Q3 FY2014
As of Mar 31, 2014
|
Q2 FY2014
As of Dec 31, 2013
|
Q1 FY2014
As of Sep 30, 2013
|
Q4 FY2013
As of Jun 30, 2013
|
Q3 FY2013
As of Mar 31, 2013
|
Q2 FY2013
As of Dec 31, 2012
|
Q1 FY2013
As of Sep 30, 2012
|
Q4 FY2012
As of Jun 30, 2012
|
Q3 FY2012
As of Mar 31, 2012
|
Q2 FY2012
As of Dec 31, 2011
|
Q1 FY2012
As of Sep 30, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Exclusive brand licenses, trademarks and intangibles, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Debt financing costs, net | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Accounts payable - trade | ||||||||||||||||||||
| Other payables and accrued expenses | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term Liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Deferred income taxes and other liabilities | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable noncontrolling interest (See Note 5) | ||||||||||||||||||||
| Redeemable noncontrolling interest (see Note 12) | ||||||||||||||||||||
| Redeemable Series A Serial Preferred Stock, $0.01 par value 50,000 shares authorized: 50,000 shares issued and outstanding | ||||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||||
| Common stock, $0.01 par value, 50,000,000 shares authorized; 34,790,625 and 34,652,963 shares issued, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Treasury stock (4,841,308 shares at cost) | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total Elizabeth Arden shareholders' equity | ||||||||||||||||||||
| Noncontrolling interest (See Note 12) | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities, redeemable noncontrolling interest, redeemable preferred stock and shareholders' equity |
Loading...
